Plavix (clopidogrel), to prevent recurrent MI or ischemic stroke
December 1997
Bristol-Myers Squibb will soon promote Plavix (clopidogrel), to prevent recurrent MI or ischemic stroke.
Plavix is a new platelet inhibitor. It's chemically similar to Ticlid (ticlopidine)...but without the risk of neutropenia.
Plavix is slightly more effective than aspirin.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote